Business Description
Thyrocare Technologies Ltd
ISIN : INE594H01019
Compare
Compare
Traded in other countries / regions
THYROCARE.India IPO Date
2016-05-09Description
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.25 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.29 | |||||
| Interest Coverage | 21.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 18.91 | |||||
| Beneish M-Score | -3.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.1 | |||||
| 3-Year EBITDA Growth Rate | -7 | |||||
| 3-Year EPS without NRI Growth Rate | -12.5 | |||||
| 3-Year FCF Growth Rate | 6.5 | |||||
| 3-Year Book Growth Rate | 7.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.32 | |||||
| 9-Day RSI | 37.32 | |||||
| 14-Day RSI | 43.05 | |||||
| 6-1 Month Momentum % | 14.4 | |||||
| 12-1 Month Momentum % | 42.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.08 | |||||
| Quick Ratio | 2.55 | |||||
| Cash Ratio | 1.99 | |||||
| Days Inventory | 78.44 | |||||
| Days Sales Outstanding | 39.14 | |||||
| Days Payable | 59.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.9 | |||||
| Dividend Payout Ratio | 1.34 | |||||
| 3-Year Dividend Growth Rate | 21.6 | |||||
| 5-Year Yield-on-Cost % | 6.17 | |||||
| Shareholder Yield % | 2.14 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.85 | |||||
| Operating Margin % | 15.85 | |||||
| Net Margin % | 12.37 | |||||
| FCF Margin % | 18.54 | |||||
| ROE % | 13.72 | |||||
| ROA % | 11.36 | |||||
| ROIC % | 14.68 | |||||
| ROC (Joel Greenblatt) % | 41.01 | |||||
| ROCE % | 18.41 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.88 | |||||
| PE Ratio without NRI | 46.88 | |||||
| Shiller PE Ratio | 32.39 | |||||
| Price-to-Owner-Earnings | 38.15 | |||||
| PS Ratio | 5.79 | |||||
| PB Ratio | 6.31 | |||||
| Price-to-Tangible-Book | 7.78 | |||||
| Price-to-Free-Cash-Flow | 31.23 | |||||
| Price-to-Operating-Cash-Flow | 19.76 | |||||
| EV-to-EBIT | 31.45 | |||||
| EV-to-EBITDA | 21.44 | |||||
| EV-to-Revenue | 5.51 | |||||
| EV-to-FCF | 30.06 | |||||
| Price-to-Projected-FCF | 6.3 | |||||
| Price-to-Graham-Number | 4 | |||||
| Price-to-Net-Current-Asset-Value | 20.34 | |||||
| Price-to-Net-Cash | 52.23 | |||||
| Earnings Yield (Greenblatt) % | 3.18 | |||||
| FCF Yield % | 3.23 | |||||
| Forward Rate of Return (Yacktman) % | -3.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thyrocare Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 5,718.8 | ||
| EPS (TTM) (₹) | 13.4 | ||
| Beta | 0.8 | ||
| Volatility % | 35.74 | ||
| 14-Day RSI | 43.05 | ||
| 14-Day ATR (₹) | 19.842947 | ||
| 20-Day SMA (₹) | 632.4375 | ||
| 12-1 Month Momentum % | 42.53 | ||
| 52-Week Range (₹) | 449.95 - 722 | ||
| Shares Outstanding (Mil) | 52.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thyrocare Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thyrocare Technologies Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Thyrocare Technologies Ltd Frequently Asked Questions
What is Thyrocare Technologies Ltd(BOM:539871)'s stock price today?
The current price of BOM:539871 is ₹620.00. The 52 week high of BOM:539871 is ₹722.00 and 52 week low is ₹449.95.
When is next earnings date of Thyrocare Technologies Ltd(BOM:539871)?
The next earnings date of Thyrocare Technologies Ltd(BOM:539871) is .
Does Thyrocare Technologies Ltd(BOM:539871) pay dividends? If so, how much?
The Dividend Yield %  of Thyrocare Technologies Ltd(BOM:539871) is 2.9% (As of Today), Highest Dividend Payout Ratio of Thyrocare Technologies Ltd(BOM:539871) was 1.59. The lowest was 0.33. And the median was 0.6. The  Forward Dividend Yield % of Thyrocare Technologies Ltd(BOM:539871) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers